Coherus BioSciences, Inc. Annual Costs and Expenses in USD from 2018 to 2024

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Coherus BioSciences, Inc. quarterly/annual Costs and Expenses history and growth rate from 2018 to 2024.
  • Coherus BioSciences, Inc. Costs and Expenses for the quarter ending December 31, 2024 was $96.4M, a 39.9% decline year-over-year.
  • Coherus BioSciences, Inc. Costs and Expenses for the twelve months ending December 31, 2024 was $379M, a 17.8% decline year-over-year.
  • Coherus BioSciences, Inc. annual Costs and Expenses for 2024 was $379M, a 17.8% decline from 2023.
  • Coherus BioSciences, Inc. annual Costs and Expenses for 2023 was $460M, a 1.6% decline from 2022.
  • Coherus BioSciences, Inc. annual Costs and Expenses for 2022 was $468M, a 20.7% decline from 2021.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Annual (USD)
Costs and Expenses, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $379M -$81.8M -17.8% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-17
2023 $460M -$7.48M -1.6% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-17
2022 $468M -$122M -20.7% Jan 1, 2022 Dec 31, 2022 10-K 2025-03-17
2021 $590M +$271M +84.8% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-15
2020 $320M +$71.2M +28.7% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-06
2019 $248M +$43.9M +21.5% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-23
2018 $204M Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.